πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 93 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9340547

Pyrrolotriazinone derivatives as inhibitors P13K

Almirall, S.A. Β· Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9333195

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9315463

Cyclohexylamine derivatives having Ξ²2 adrenergic agonist and M3 muscarinic antagonist acti

Almirall, S.A. Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9254262

Dosage and formulation

Almirall, S.A. Β· Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9233108

Cyclohexylamine derivatives having Ξ²2 adrenergic agonist and M3 muscarinic antagonist acti

Almirall, S.A. Β· Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9206183

Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors

Almirall, S.A. Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9133200

Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors

Almirall, S.A. Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9108918

Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl

Almirall, S.A. Β· Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056100

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9034311

Pyridin-2(1 H)-one derivatives as JAK inhibitors

Almirall, S.A. Β· Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865728

Combinations comprising methotrexate and DHODH inhibitors

Almirall, S.A. Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802699

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8772288

Substituted spiro[cycloalkyl-1,3β€²-indo]-2β€²(1β€²H)-one derivatives and their use as P38 mitog

Almirall, S.A. Β· Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8569320

Topical composition for the treatment of actinic keratosis

Almirall Hermal GmbH Β· Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563731

Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hyd

Almirall, S.A. Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8536165

Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

Almirall, S.A. Β· Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524908

Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethy

Almirall, S.A. Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8513279

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501943

Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid a

Almirall, S.A. Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8450341

Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibi

Almirall, S.A. Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420669

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic recept

Laboratories Almirall, S.A. Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8334294

4,8-diphenyl-polyazanaphthalene derivatives

Almirall, S.A. Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8283342

Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8

Almirall, S.A. Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8258308

Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted